LIGNIN - CHOLESTEROL-LOWERING AGENT

被引：0
|
作者：
LINDNER, P [1 ]
MOLLER, B [1 ]
机构：
[1] SUNDSVALL HOSP,S-851 86 SUNDSVALL,SWEDEN
来源：
LANCET | 1973年 / 2卷 / 7840期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1259 / 1260
页数：2
相关论文
共 50 条
  • [41] Risks of cholesterol-lowering therapies
    Hibbeln, JR
    Salem, N
    BIOLOGICAL PSYCHIATRY, 1996, 40 (07) : 686 - 687
  • [42] ADHERENCE TO CHOLESTEROL-LOWERING DIETS
    GRUNDY, SM
    ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (06) : 1139 - 1139
  • [43] CHOLESTEROL-LOWERING AGENTS AND CHOLELITHIASIS
    LOFLAND, HB
    CLARKSON, TB
    ARTERY, 1975, 1 (03) : 226 - 227
  • [44] Pharmacogenomics of cholesterol-lowering therapy
    Schmitz, G
    Langmann, T
    VASCULAR PHARMACOLOGY, 2006, 44 (02) : 75 - 89
  • [45] CHOICE OF CHOLESTEROL-LOWERING DRUGS
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1988, 30 (774): : 85 - 88
  • [46] CHOLESTEROL-LOWERING, LOW-CHOLESTEROL, AND MORTALITY
    LAROSA, JC
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (11): : 776 - 786
  • [47] Inclisiran: present and future perspectives of a new effective LDL cholesterol-lowering agent
    Giordano, Salvatore
    Polimeni, Alberto
    Esposito, Giovanni
    Indolfi, Ciro
    Spaccarotella, Carmen
    CURRENT OPINION IN LIPIDOLOGY, 2023, 34 (04) : 133 - 140
  • [48] Cholesterol-lowering agent myopathy: Clinical, electrophysiologic, and pathologic data in five patients
    Meriggioli, MN
    Barboi, AC
    Rowin, J
    Cochran, EJ
    NEUROLOGY, 2000, 54 (07) : A439 - A439
  • [49] RPR107393 - A SQUALENE SYNTHASE INHIBITOR AND A POTENT CHOLESTEROL-LOWERING AGENT
    AMIN, D
    NEEDLE, S
    RUTLEDGE, R
    GALCZENSKI, H
    BUSH, R
    HELE, D
    MAGUIRE, M
    NEUENSCHWANDER, K
    SPADA, A
    BILDER, G
    ROACH, A
    PERRONE, M
    FASEB JOURNAL, 1995, 9 (04): : A766 - A766
  • [50] A unique cholesterol-lowering agent that no one had ever had before - Comment
    Yamamoto, A
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (03) : 20 - 20
12345